Drug Safety - Table 2
Table 2. Laboratory monitoring for established disease modifying anti-rheumatic drugs (DMARDs) (Frequency in Weeks)*
DRUG |
Hemoglobin
or Hematocrit |
WBC |
Platelet
Count |
Serum Creatinine |
AST
or
ALT |
Albumin |
Urinary Protein |
Other |
Hydroxychloroquine |
|
|
|
|
|
|
|
Fundoscopic exam and visual fields annually |
Sulfasalazine |
12 |
12 |
12 |
|
|
|
|
|
Methotrexate |
8 |
8 |
8 |
8 |
8 |
8 |
|
|
Leflunomide |
8 |
8 |
8 |
8 |
8 |
8 |
|
|
Azathioprine |
12 |
12 |
12 |
|
|
|
|
|
Intramuscular Gold |
8 |
8 |
8 |
|
|
|
8 |
|
Oral Gold |
12 |
12 |
12 |
|
|
|
12 |
|
Cyclosporine |
|
|
|
4 |
|
|
|
|
Glucocorticoids |
|
|
|
|
|
|
|
Urine or blood glucose annually |
*WBC = white blood cell count; AST = aspartate aminotransferase; ALT = alanine aminotransferas
Back to Drug Safety QPI
